User banner image
User avatar
  • admin

Posts

Verrica Pharmaceuticals Announces Presentation of Three Posters Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2025 Winter Clinical Dermatology Conference

– Presented data includes a 97% Calculated Objective Response Rate (ORR) of study subjects following treatment with VP-315 – Posters highlight the safety data, tolerability...

Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality

Ms. Colacot brings over 25 years of quality leadership experience across the biopharmaceutical and medical device industries NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) —...

Scilex Holding Company Announces that It Will Be Filing Today of a Supplemental New Drug Application with the FDA for ELYXYB® in Acute Pain Indication

ELYXYB®, a rapid onset and ready-to-use formulation of Celecoxib, delivers a first line non-opioid therapeutic alternative to habit-forming opioids and acetaminophen, the leading cause of...

VINI JR. SADDLES-UP, WHILE JACK GREALISH HEADS TO JUNGLE IN LATEST PEPSI® CAMPAIGN

 THE CAMPAIGN ENCOURAGES FOOTBALL FANS TO DITCH MIDWEEK ROUTINE FOR UEFA CHAMPIONS LEAGUE ACTION Campaign features two films with Pepsi ambassador Vini Jr. The first, unveiled...

Tuya to Release Smart Door Lock Solution with Matter and Home Key in Apple Wallet Support

NEW YORK, Jan. 21, 2025 /PRNewswire/ —Tuya Smart (NYSE: TUYA, HKEX: 2391), the global cloud platform service provider today introduced a new smart door lock...

Harry Theoharis Announces Candidacy for Secretary General of UN Tourism

Presents programme for reform and transformation of the key UN agency at FITUR 2025 Gains key endorsement from African Tourism Board MADRID, Jan. 21, 2025...

ChipMOS ANNOUNCES NT$350 MILLION SHARE REPURCHASE PROGRAM

HSINCHU, Jan. 21, 2025 /PRNewswire-FirstCall/ — ChipMOS TECHNOLOGIES INC. (“ChipMOS” or the “Company”) (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS), an industry leading provider of...

Ascletis Announces Positive Results from U.S. Phase Ia Single Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Provides Program Update

ASC30 oral tablet demonstrated dose-proportional pharmacokinetic (PK) properties and a long half-life (t1/2) up to 60 hours in the single ascending dose (SAD) study of...

Global Cosmetic Ingredients Market is expected to reach revenue of USD 61.2 Bn by 2033, at 6.2% CAGR: Dimension Market Research.

Advancements and Projections in the Global Cosmetic Ingredients Market: Insights, Trends, Opportunities, and Recent Developments New York, Jan. 20, 2025 (GLOBE NEWSWIRE) — Overview The...

Global Vitamin B3 Market to Hit Valuation of US$ 521.26 Million By 2033 | Astute Analytica

Vitamin B3 demand expands due to advanced extraction techniques, rising health-conscious consumers, and robust research-driven applications in pharmaceuticals, supplements, and feed, shaping a dynamic market...